{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:17:19Z","timestamp":1778872639468,"version":"3.51.4"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Folates, the main actors in one-carbon (C1) metabolism, are involved in synthesising monoamines and maintaining genomic stability. Previous studies support the association between C1 metabolism and schizophrenia. The main purpose of this study was to assess the prevalence of plasma folate, and\/or vitamin B12 deficiencies and hyperhomocysteinemia in young patients with psychotic disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included young inpatients (15\u201330 years old) with psychosis between 2014 and 2017 from Sainte-Anne Hospital in Paris. Plasma folate, vitamin B12 deficiency and homocysteinemia dosages were done at admission. Clinical data were extracted retrospectively, and patients diagnosed with a first-episode psychosis (FEP), schizophrenia, schizoaffective disorder, or persistent delusional disorder were retained for the analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 334 inpatients, 188 (56%) had C1 dosages available (135 males; 53 females). From the 188 patients, 32% had a C1 abnormality. This abnormality reached 38% of FEP patients. The most frequent abnormality was folate deficiency: 21% of all patients and 27% of FEP. Lower levels of folates were found in males compared to females (<jats:italic>p<\/jats:italic> = 0.02) and were correlated with more severe disorder, as assessed by Clinical Global Impression \u2013 Severity (CGI-S; <jats:italic>p<\/jats:italic> = 0.009). Antipsychotic dosage was positively associated with B12 levels (<jats:italic>p<\/jats:italic> = 0.013) and negatively with homocysteinemia (<jats:italic>p<\/jats:italic> = 0.034).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>One-carbon metabolism anomalies in young patients with psychotic disorders are highly prevalent, reaching almost half of the patients with FEP. Potential protective effects from females and antipsychotics have emerged. These results spotlight the need for new therapeutic prospects, such as folate supplementation, to achieve personalised medical approaches to the early stages of psychotic disorders.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1128890","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T05:18:44Z","timestamp":1675228724000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Abnormalities in one-carbon metabolism in young patients with psychosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Ariel","family":"Frajerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Rivollier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Plaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Chaumette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Odile","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Scoriels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.molmed.2009.10.001","article-title":"One-carbon metabolism and schizophrenia: current challenges and future directions.","volume":"15","author":"Krebs","year":"2009","journal-title":"Trends Mol Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.encep.2014.06.005","article-title":"[Epigenetics of schizophrenia: a review].","volume":"40","author":"Rivollier","year":"2014","journal-title":"Encephale."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.4088\/jcp.v69n0901","article-title":"L-methylfolate: a vitamin for your monoamines.","volume":"69","author":"Stahl","year":"2008","journal-title":"J Clin Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/nu8020068","article-title":"Vitamins and the brain: mechanisms, dose and efficacy\u2013a review.","volume":"8","author":"Kennedy","year":"2016","journal-title":"Nutrients."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.976428","article-title":"Association between variants of MTHFR genes and psychiatric disorders: a meta-analysis.","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Psychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ymgme.2014.10.002","article-title":"Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies.","volume":"113","author":"Ramaekers","year":"2014","journal-title":"Mol Genet Metab."},{"key":"B7","first-page":"196","article-title":"Folate and cancer. The right dose.","volume":"15","author":"Guilland","year":"2011","journal-title":"Corresp MHDN."},{"key":"B8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/10673220701551136","article-title":"The role of one-carbon metabolism in schizophrenia and depression.","volume":"15","author":"Frankenburg","year":"2007","journal-title":"Harv Rev Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ana.22229","article-title":"Antiepileptic drugs interact with folate and vitamin B12 serum levels.","volume":"69","author":"Linnebank","year":"2011","journal-title":"Ann Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.3390\/nu7042663","article-title":"Assessing the association between natural food folate intake and blood folate concentrations: a systematic review and bayesian meta-analysis of trials and observational studies.","volume":"7","author":"Marchetta","year":"2015","journal-title":"Nutrients."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2016.03.003","article-title":"Lower folate levels in schizophrenia: a meta-analysis.","volume":"245","author":"Cao","year":"2016","journal-title":"Psychiatry Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.psychres.2015.11.045","article-title":"Serum folate levels in schizophrenia: a meta-analysis.","volume":"235","author":"Wang","year":"2016","journal-title":"Psychiatry Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.pnpbp.2007.05.011","article-title":"Plasma homocysteine, folate and B12 in chronic schizophrenia.","volume":"31","author":"Haidemenos","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/sj.mp.4001746","article-title":"Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis.","volume":"11","author":"Muntjewerff","year":"2006","journal-title":"Mol Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.841429","article-title":"The effects of plasma homocysteine level on the risk of three major psychiatric disorders: a Mendelian randomization study.","volume":"13","author":"Yu","year":"2022","journal-title":"Front Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99239-3","article-title":"Association between plasma homocysteine levels and cognitive deficits in Han Chinese patients with schizophrenia across age groups.","volume":"11","author":"Zhou","year":"2021","journal-title":"Sci Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.pnpbp.2005.06.024","article-title":"Aberrant folate status in schizophrenic patients: what is the evidence?","volume":"29","author":"Muntjewerff","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neulet.2017.04.025","article-title":"Effect of risperidone on serum homocysteine levels in first-episode, drug-na\u00efve patients with schizophrenia.","volume":"650","author":"Fan","year":"2017","journal-title":"Neurosci Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.psychres.2009.01.013","article-title":"Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism.","volume":"175","author":"Kale","year":"2010","journal-title":"Psychiatry Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.psychres.2016.01.077","article-title":"Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism.","volume":"238","author":"Misiak","year":"2016","journal-title":"Psychiatry Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1038\/tp.2015.26","article-title":"Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission.","volume":"5","author":"Scoriels","year":"2015","journal-title":"Transl Psychiatry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s11011-014-9534-3","article-title":"Elevated homocysteine level in first-episode schizophrenia patients\u2014The relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse.","volume":"29","author":"Misiak","year":"2014","journal-title":"Metab Brain Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1176\/appi.ajp.161.9.1705","article-title":"Folate, homocysteine, and negative symptoms in schizophrenia.","volume":"161","author":"Goff","year":"2004","journal-title":"Am J Psychiatry."},{"key":"B24","first-page":"S437","article-title":"Folate and vitamin B12 status in schizophrenic patients.","volume":"16","author":"Saedisomeolia","year":"2011","journal-title":"J Res Med Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/schbul\/sbx162","article-title":"Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis.","volume":"44","author":"Firth","year":"2017","journal-title":"Schizophr Bull."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136826","article-title":"Serum hyperhomocysteine and cognitive impairment in first-episode patients with schizophrenia: moderated by brain cortical thickness.","volume":"788","author":"Lin","year":"2022","journal-title":"Neurosci Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/schbul\/sbr150","article-title":"Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia.","volume":"39","author":"Roffman","year":"2013","journal-title":"Schizophr Bull."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.05.005","article-title":"Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia.","volume":"78","author":"Mitra","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s12035-017-0493-7","article-title":"The evaluation of folic acid-deficient or folic acid-supplemented diet in the gestational phase of female rats and in their adult offspring subjected to an animal model of schizophrenia.","volume":"55","author":"Canever","year":"2018","journal-title":"Mol Neurobiol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0140-6736(90)91942-4","article-title":"Enhancement of recovery from psychiatric illness by methylfolate.","volume":"336","author":"Godfrey","year":"1990","journal-title":"Lancet Lond Engl."},{"key":"B31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/mp.2017.41","article-title":"Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial.","volume":"23","author":"Roffman","year":"2018","journal-title":"Mol Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.schres.2010.12.006","article-title":"Folate supplementation in schizophrenia: a possible role for MTHFR genotype.","volume":"127","author":"Hill","year":"2011","journal-title":"Schizophr Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jad.2020.01.096","article-title":"Adjunctive folate for major mental disorders: a systematic review.","volume":"267","author":"Zheng","year":"2020","journal-title":"J Affect Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.biopsych.2018.12.018","article-title":"The vitamins in psychosis study: a randomized, double-blind, placebo-controlled trial of the effects of vitamins B12, B6, and folic acid on symptoms and neurocognition in first-episode psychosis.","volume":"86","author":"Allott","year":"2019","journal-title":"Biol Psychiatry."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.900","article-title":"Randomized multicenter investigation of folate plus vitamin B 12 supplementation in schizophrenia.","volume":"70","author":"Roffman","year":"2013","journal-title":"JAMA Psychiatry."},{"key":"B36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4088\/JCP.8157su1c.03","article-title":"Folate in depression: efficacy, safety, differences in formulations, and clinical issues.","volume":"70","author":"Fava","year":"2009","journal-title":"J Clin Psychiatry."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/nu8100594","article-title":"Excess folic acid increases lipid storage, weight gain, and adipose tissue inflammation in high fat diet-fed rats.","volume":"8","author":"Kelly","year":"2016","journal-title":"Nutrients."},{"key":"B38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/bs.afnr.2017.12.006","article-title":"Recent developments in folate nutrition.","volume":"83","author":"Naderi","year":"2018","journal-title":"Adv Food Nutr Res."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136881","article-title":"Shared biological pathways between antipsychotics and omega-3 fatty acids: a key feature for schizophrenia preventive treatment?","volume":"22","author":"Frajerman","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/pcn.13074","article-title":"Association between serum folate levels and schizophrenia based on sex.","volume":"74","author":"Tomioka","year":"2020","journal-title":"Psychiatry Clin Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00228-014-1762-2","article-title":"Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients.","volume":"70","author":"Misiak","year":"2014","journal-title":"Eur J Clin Pharmacol."},{"key":"B42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1017\/S0007114500002518","article-title":"5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en vitamines et mineraux antioxydants (SU.VI.MAX) cohort.","volume":"84","author":"Chango","year":"2000","journal-title":"Br J Nutr."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.pnpbp.2008.09.009","article-title":"Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia.","volume":"32","author":"Petronijevi\u0107","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B45","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1177\/15648265080292S129","article-title":"Conclusions of a WHO technical consultation on folate and vitamin B12 deficiencies.","volume":"29","author":"de Benoist","year":"2008","journal-title":"Food Nutr Bull."},{"key":"B46","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1177\/15648265080292S110","article-title":"The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status.","volume":"29","author":"Selhub","year":"2008","journal-title":"Food Nutr Bull."},{"key":"B47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biochi.2016.04.005","article-title":"The basis for folinic acid treatment in neuro-psychiatric disorders.","volume":"126","author":"Ramaekers","year":"2016","journal-title":"Biochimie."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1128890\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T05:18:49Z","timestamp":1675228729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1128890\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":47,"alternative-id":["10.3389\/fpsyt.2023.1128890"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1128890","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"article-number":"1128890"}}